[PDF][PDF] Quantitative analysis and expression of salivary opiorphin in painful oral soft-tissue conditions: A descriptive study

NK Nejad, KA RP, S Sujatha - J Global Oral Health, 2020 - researchgate.net
Objectives: Opiorphin is an enkephalinase inhibitor which suppresses pain by acting on the
opioid system. The levels of opiorphin in plasma and saliva have shown to vary in patients …

Salivary opiorphin in dental pain: A potential biomarker for dental disease

MS Ozdogan, M Gungormus, SI Yusufoglu… - Archives of Oral …, 2019 - Elsevier
Objectives Opiorphin is a recently discovered peptide shown to inhibit the enkephalin-
degrading enzymes and prolong the effects of enkephalins. Although opiorphin is found in …

Opiorphin in burning mouth syndrome patients: a case-control study

I Salarić, M Sabalić, I Alajbeg - Clinical Oral Investigations, 2017 - Springer
Objectives Opiorphin is a pentapeptide isolated from human saliva that suppresses pain
from chemically induced inflammation and acute physical pain. Burning mouth syndrome …

[HTML][HTML] Assessment of salivary opiorphin in oral lichen planus

Z Dalirsani, M Amirchaghmaghi, A Ghazi… - Brazilian Journal of …, 2024 - SciELO Brasil
Opiorphin is a pentapeptide, which could be isolated from human fluids and has a
decreasing effect on pain. Aim Since lichen planus is a chronic mucocutaneous disease …

Salivary opiorphin levels in denture‐related traumatic ulcers

MS Ozdogan, M Gungormus - Oral Diseases, 2023 - Wiley Online Library
Objective Opiorphin is a pentapeptide secreted in saliva and has a strong analgesic effect.
Salivary opiorphin has been shown to increase in orofacial pain and may act as a pain …

A study of salivary opiorphin levels using different anesthetic drugs and techniques–A randomized controlled clinical study

SK Parida, T Guruprasad, VB Krishnakumar… - Journal of stomatology …, 2018 - Elsevier
Purpose This study aimed at assessing the change in salivary opiorphin levels before and
after administration of local anesthesia, with the use of three different local anesthetic …

Time-course of pain and salivary opiorphin release in response to oral capsaicin differ in burning mouth syndrome patients, temporomandibular disorders patients and …

IZ Alajbeg, E Vrbanovic, I Alajbeg, I Orabovic… - Clinical Oral …, 2024 - Springer
Objectives Opiorphin is an analgesic peptide released by salivary glands and capsaicin an
agonist of TRPV1 receptors eliciting burning sensations. The primary objective of this study …

Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study

Y Boucher, A Braud, E Dufour, S Agbo-Godeau… - Clinical oral …, 2017 - Springer
Abstract Objectives Idiopathic Burning mouth syndrome (iBMS) is a poorly understood
affection characterized by persistent pain in the oral cavity without any clinical or biological …

Development and validation of a liquid chromatography–tandem mass spectrometry method for the quantification of opiorphin in human saliva

L Brkljačić, M Sabalić, I Salarić, I Jerić, I Alajbeg… - … of Chromatography B, 2011 - Elsevier
Opiorphin, QRFSR-peptide, is a mature product of the PROL1 (proline rich, lacrimal 1)
protein that showed beneficial effects in pain management, antidepressant-like actions as …

Salivary opiorphin levels in anorexia nervosa: A case–control study

E Paszynska, M Dmitrzak-Weglarz… - The World Journal of …, 2020 - Taylor & Francis
Objectives: Opiorphin is a physiological inhibitor of peptidases inactivating endogenous
opioids displaying strong analgesic properties without undesirable side effects …